Literature DB >> 8307431

Gall stone pulverisation strategy in patients treated with extracorporeal lithotripsy and follow up results of maintenance treatment with ursodeoxycholic acid.

M Boscaini1, M Piccinni-Leopardi, F Andreotti, A Montori.   

Abstract

Between November 1988 and July 1992 70 patients with radiolucent gall stones were treated with extracorporeal lithotripsy (ESL) and ursodeoxycholic acid (UDCA; mean (SD) dose 11.2 (1.9) mg/kg/day). Fifty three patients have been followed for one year. One week after lithotripsy, 30.6% had completely eliminated all stone fragments from the gall bladder and one year later 93.9% were free of stones. Three factors were considered important in achieving these results. 'Pulverisation' of the stone--that is, its fragmentation into echogenic dust (crystalline aggregates, some few hundred mu in size) or particles similar to grains of sand, smaller than 1 mm in diameter, or both, is required. Secondly, dust and particles were rapidly eliminated, strongly suggesting a mechanical elimination process by physiological gall bladder contractions. Thirdly, there must be chemical dissolution with biliary acids. This therapeutic approach gave excellent results without causing any clinically relevant side effects. The first 20 patients who became free of stones after ESL were given oral bile acid maintenance treatment--300 mg/day of UDCA at bedtime, for two years. All were asymptomatic and none had suffered a recurrence after two years. In four patients, crystalline aggregates, detected in gall bladder bile by ultrasound, were subsequently dissolved between one and three months after resuming a full dose regimen of UDCA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8307431      PMCID: PMC1374645          DOI: 10.1136/gut.35.1.117

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  Morphological appearance of low-level echoes in the gallbladder. Interpretation with microscopic biliary analysis and clinical correlation.

Authors:  M Boscaini; G Magnani; S Mandetta; A Montori
Journal:  Surg Endosc       Date:  1987       Impact factor: 4.584

2.  The effect of ursodiol on the efficacy and safety of extracorporeal shock-wave lithotripsy of gallstones. The Dornier National Biliary Lithotripsy Study.

Authors:  L J Schoenfield; G Berci; R L Carnovale; W Casarella; P Caslowitz; D Chumley; R C Davis; J Y Gillenwater; A C Johnson; R S Jones
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

3.  Comet-tail artifact from cholesterol crystals: observations in the postlithotripsy gallbladder and an in vitro model.

Authors:  R S Shapiro; F Winsberg
Journal:  Radiology       Date:  1990-10       Impact factor: 11.105

4.  Gallbladder stone fragments in feces after biliary extracorporeal shock-wave lithotripsy.

Authors:  L Greiner; C Münks; W Heil; C Jakobeit
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

5.  Is recurrence inevitable after gallstone dissolution by bile-acid treatment?

Authors:  D C Ruppin; R H Dowling
Journal:  Lancet       Date:  1982-01-23       Impact factor: 79.321

6.  Use of external shock-wave lithotripsy and adjuvant ursodiol for treatment of radiolucent gallstones. A national multicenter study.

Authors:  D Burnett; A Ertan; R Jones; J P O'Leary; R Mackie; J E Robinson; G Salen; L Stahlgren; D H Van Thiel; L Vassy
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

7.  [Recurrence and prevention of recurrence after dissolution of gallbladder lithiasis by chenodeoxycholic acid in 22 patients].

Authors:  J Toulet; J Rousselet; J M Viteau; Y Duchon; R Pagniez; B Samain; J L Vienne
Journal:  Gastroenterol Clin Biol       Date:  1983 Jun-Jul

8.  The Munich Gallbladder Lithotripsy Study. Results of the first 5 years with 711 patients.

Authors:  M Sackmann; J Pauletzki; T Sauerbruch; J Holl; G Schelling; G Paumgartner
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

9.  Gallstone dissolution therapy with ursodiol. Efficacy and safety.

Authors:  G Salen
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

10.  Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up.

Authors:  L D O'Donnell; K W Heaton
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

View more
  2 in total

1.  Repeated piezoelectric lithotripsy for gallstones with and without ursodeoxycholic acid dissolution: a multicenter study.

Authors:  Y Tsuchiya; F Ishihara; G Kajiyama; S Nakazawa; M Otho; H Tanimura; Y Akura; M Harada; M Hihara; Y Kawai
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

2.  What is the exact definition of stone dust? An in vitro evaluation.

Authors:  Etienne Xavier Keller; Vincent De Coninck; Steeve Doizi; Michel Daudon; Olivier Traxer
Journal:  World J Urol       Date:  2020-04-08       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.